Haleon plc (NYSE:HLN) Shares Sold by Blue Trust Inc.

Blue Trust Inc. cut its holdings in shares of Haleon plc (NYSE:HLNFree Report) by 42.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,211 shares of the company’s stock after selling 9,579 shares during the period. Blue Trust Inc.’s holdings in Haleon were worth $109,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Washington Trust Advisors Inc. lifted its position in Haleon by 353.3% in the third quarter. Washington Trust Advisors Inc. now owns 2,960 shares of the company’s stock worth $25,000 after purchasing an additional 2,307 shares during the period. Farther Finance Advisors LLC lifted its position in Haleon by 79.3% in the second quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock worth $25,000 after purchasing an additional 1,321 shares during the period. CoreFirst Bank & Trust acquired a new stake in Haleon in the fourth quarter worth approximately $26,000. Barclays PLC lifted its position in Haleon by 56.4% in the second quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after purchasing an additional 1,196 shares during the period. Finally, Resurgent Financial Advisors LLC acquired a new stake in Haleon in the fourth quarter worth approximately $29,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Argus restated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on Haleon

Haleon Trading Down 0.4 %

Shares of HLN opened at $8.25 on Thursday. The business’s 50-day moving average price is $8.32 and its 200 day moving average price is $8.29. The stock has a market capitalization of $37.65 billion, a P/E ratio of 29.45, a P/E/G ratio of 2.18 and a beta of 0.29. Haleon plc has a 1-year low of $7.70 and a 1-year high of $9.05. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53.

Haleon Announces Dividend

The business also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date of this dividend is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio is currently 75.00%.

Haleon Company Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Read More

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.